Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Guggenheim Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT)
-
SLB (SLB) PT Lowered to $50 at Stifel
-
Guggenheim Reiterates Buy Rating on Humana (HUM)
-
-
-
-
-
-
-
Kratos Defense & Security (KTOS) PT Raised to $70 at Stifel
-
-
-
-
-
-
-
Citi Reiterates Neutral Rating on Stellantis NV (STLA:FP) (STLA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)
-
-
-
-
-
-
-
FirstEnergy Corp. (FE) PT Raised to $43 at Jefferies
-
-
-
-
-
-
-
Elevance (ELV) PT Lowered to $330 at TD Cowen
-
-
-
-
-
-
-
Washington Federal (WAFD) PT Raised to $33 at Stephens
-
-
-
-
-
424,676 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.